Litcius/Paper detail

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

Joao V. Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Victor R. Vaz, Giuseppe Lamberti, Rosa L. Frias, Deepti Venkatraman, Claudia Angela Maria Fulgenzi, Federica Pecci, Gonzalo Recondo, Alessandro Di Federico, Adriana P C Barrichello, Hyesun Park, Mizuki Nishino, Grace M. Hambelton, Jacklynn V. Egger, Marc Ladanyi, Subba R. Digumarthy, Bruce E. Johnson, David C. Christiani, Xihong Lin, Justin F. Gainor, W. Marston Linehan, David J. Pinato, Adam J. Schoenfeld, Mark M. Awad

2023Journal of Thoracic Oncology91 citationsDOIOpen Access PDF

Topics & Concepts

ChemoimmunotherapyMedicineInternal medicineOncologyBlockadeProgression-free survivalChemotherapyGastroenterologyCancerImmunotherapyReceptorCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC | Litcius